Fluctuations in serotonin transport may explain winter blues

September 09, 2008

Why do many Canadians get the winter blues? In the first study of its kind in the living human brain, Dr. Jeffrey Meyer and colleagues at the Centre for Addiction and Mental Health (CAMH) have discovered greater levels of serotonin transporter in the brain in winter than in summer. These findings have important implications for understanding seasonal mood change in healthy people, vulnerability to seasonal affective disorders and the relationship of light exposure to mood.

CAMH's scientific team discovered that the serotonin transporter levels were significantly higher in all investigated brain regions in individuals studied in fall/winter, compared to those studied in spring/summer in a study of healthy subjects. Serotonin transporters remove serotonin so this discovery argues that there is more serotonin removal in the fall/winter as compared to spring/summer. Also, the higher serotonin transporter binding values occurred at times when there is less sunlight. This is the first time scientists have found differences in serotonin transporter levels in the brain in fall/winter versus spring/summer.

Serotonin is involved in regulating physical functions such as eating and energy balance, and emotional functions like mood and energy levels. These phenomena vary across the seasons and the molecular background for why this happens was previously unknown. For this study, Dr. Jeffrey Meyer and his team used a world-leading positron emission tomography (PET) technology (originally created at CAMH by Dr. Alan Wilson) to detect these seasonal variations in serotonin transporter binding (the process that removes serotonin) in the living human brain and correlations between serotonin binding and duration of daily sunshine.

As Dr. Meyer explains, this is "an important lead in understanding how season changes serotonin levels. This offers an explanation for why some healthy people experience low mood and energy in the winter, and why there is a regular reoccurrence of depressive episodes in fall and winter in some vulnerable individuals. The next steps will be to understand what causes this change and how to interfere with it."

According to the world health organization, major depressive disorder is the fourth leading cause of death and disability. Dr. Meyer points out that, "the future for treatment should be to prevent the illness itself." The presence of higher serotonin transporter levels might explain why many people experience the onset of major depressive episodes in the fall and winter. "Over the following years, we intend to determine the specifics of the environment (such as light exposure) that influence serotonin transporter levels so as to determine what is the optimal environment to prevent illness. In the future, it may be that just like we have lifestyle recommendations to prevent heart disease, we will have lifestyle recommendations to prevent major depressive disorder."

Centre for Addiction and Mental Health

---

---

	Experimental Models in Serotonin Transporter Research by Allan V. Kalueff (Editor), Justin L. LaPorte (Editor) The serotonin transporter is a key brain protein that modulates the reuptake of the neurotransmitter serotonin from synaptic spaces back into the presynaptic neuron. This control over neuronal signalling makes it a prime area of neuroscientific study. In this book an international team of top experts introduce and explicate the role of serotonin and the serotonin transporter in both human and animal brains. They demonstrate the relevance of the transporter and indeed the serotonergic system to substrates of neuropsychiatric disorders, and explain how this knowledge is translated into valid animal models that will help foster new discoveries in human neurobiology. Writing for graduate students and academic researchers, they provide a comprehensive coverage of a wide spectrum of data from...
	Human serotonin transporter: rare mutation tied to OCD, other disorders.(Adult Psychiatry): An article from: Clinical Psychiatry News by Norra MacReady (Author) This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on December 1, 2003. The length of the article is 561 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Human serotonin transporter: rare mutation tied to OCD, other disorders.(Adult Psychiatry) Author: Norra MacReady Publication: Clinical Psychiatry News (Magazine/Journal) Date: December 1, 2003 Publisher: International Medical News Group Volume: 31 Issue: 12 Page: 20(1) Distributed by Thomson...
	Depression vulnerability, cigarette smoking, and the serotonin transporter gene [An article from: Addictive Behaviors] by C.L. Brody (Author), D.H. Hamer (Author), D.A.F. Haaga (Author) This digital document is a journal article from Addictive Behaviors, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: People with current or past depression are more likely to have been smokers at some point in their lives. Smokers with depression histories are also less likely to quit. Attempts to understand this relationship are important insofar as they can help treatment efficacy for this group of smokers. Prior research indicates that different genetic variations affect the relationship between smoking and neuroticism. This study examined whether people with a short serotonin transporter genotype would likewise show a...
	Genetics of emotional regulation: the role of the serotonin transporter in neural function [An article from: Trends in Cognitive Sciences] by A.R. Hariri (Author), A. Holmes (Author) This digital document is a journal article from Trends in Cognitive Sciences, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: Identifying biological mechanisms through which genes lead to individual differences in emotional behavior is paramount to our understanding of how such differences confer risk for neuropsychiatric illness. The emergence of techniques such as in vivo imaging of brain function in humans and genetic engineering in rodents has provided important new insights into the impact of serotonin (5-HT), a key modulator of emotional behavior, on neural systems subserving anxiety and depression. A major finding has...
	A serotonin transporter gene polymorphism (5-HTTLPR), drinking-to-cope motivation, and negative life events among college students.(Report): An article from: Journal of Studies on Alcohol and Drugs by Stephen Armeli (Author), Tamlin S. Conner (Author), Jonathan Covault (Author), Howard Tennen (Author), Henry R. Kranzler (Author) This digital document is an article from Journal of Studies on Alcohol and Drugs, published by Alcohol Research Documentation, Inc. on November 1, 2008. The length of the article is 7643 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. From the author: Objective: This study was performed to examine whether a polymorphism (5-HTTLPR) in the serotonin transporter gene was related to college students' reports of relief drinking (drinking-to-cope motives) and whether it moderated the associations between negative life events and drinking to cope. We examined reward drinking (drinking-to-enhance motives) as a comparison and to see whether...
	Mutation of an asparagine in the first transmembrane domain of the human serotonin transporter results in energetic uncoupling of NA from serotonin ... of the North Dakota Academy of Science by Nathan Burbach (Author), Patrick Lamb (Author), Craig Lacher (Author), Kristin Pavlish (Author), L. Keith Henry (Author) This digital document is an article from Proceedings of the North Dakota Academy of Science, published by North Dakota Academy of Science on April 1, 2009. The length of the article is 314 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Mutation of an asparagine in the first transmembrane domain of the human serotonin transporter results in energetic uncoupling of NA from serotonin transport.(COMMUNICATIONS--UNDERGRADUATE)(Report) Author: Nathan Burbach Publication: Proceedings of the North Dakota Academy of Science (Magazine/Journal) Date: April 1, 2009 Publisher: North Dakota Academy of...
	Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of ... Journal of Studies on Alcohol and Drugs by Michael A. Dawes (Author), John D. Roache (Author), Martin A. Javors (Author), Susan E. Bergeson (Author), Dawn M. Richard (Author), Charles W. Mathias (Author), Nassima Ait-Daoud (Author), Donald M. Dougherty (Author), Bankole A. Johnson (Author) This digital document is an article from Journal of Studies on Alcohol and Drugs, published by Alcohol Research Documentation, Inc. on November 1, 2009. The length of the article is 7518 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter.(Report) Author: Michael A. Dawes Publication: Journal of Studies on Alcohol and Drugs (Magazine/Journal) Date: November 1, 2009 Publisher: Alcohol Research Documentation, Inc. Volume: 70 ...
	Gene-Environment Interaction Effects on Self-esteem: THE INFLUENCE OF THE SEROTONIN TRANSPORTER GENE AND ENVIRONMENTAL PATHOGENS ON SELF-ESTEEM DURING ADOLESCENCE AND EARLY ADULTHOOD by Charles Jonassaint (Author) Self-esteem is a well-studied construct that has been associated with a myriad of behavioral, psychological and physical health outcomes. The literature suggests that social support, socioeconomic status (SES), parental factors, maltreatment and stressful life events may influence self-esteem level and trajectory. There is also evidence for a heritable component of self-esteem. Although no large molecular genetic studies on self-esteem exist, associated personality trait neuroticism and related facets depression and anxiety have been linked to a polymorphism of the serotonin transporter gene (5HTTLPR). Therefore, the 5HTTLPR may also be associated with self-esteem. This book reviews the literature surrounding gene-environment interactions and examines the effects of...
	THE SEROTONIN TRANSPORTER GENE AND PERSONALITY:: ASSOCIATION OF THE 5-HTTLPR S ALLELE, ANXIETY, DEPRESSION AND AFFECTIVE TEMPERAMENTS by Xenia Gonda (Author) We investigated the association of depression, anxiety and affective temperaments with 5-HTTLPR. People carrying the s allele were more prone to anxiety, depression and more likely to carry affective temperaments incorporating a depressive component. From the aspect of gene-environment interactions, our results show that the presence of dominant affective temperaments and neuroticism- related traits confers increased vulnerability to chronic stress which plays a crucial role in the development of depression. Our findings open the potential to identify people with temperamental inclination to mood instability with the joint use of measures of behavioural endophenotypes and molecular genetic markers. Our findings bring psychiatric genetics closer to the aim of delineating...
	TIME COURSE OF NEURONAL DAMAGE AND RECOVERY INDUCED BY MDMA (ECSTASY): EXPRESSION AND DISTRIBUTION OF SEROTONIN TRANSPORTER IN THE RAT BRAIN by Eszter Kirilly (Author) ?Ecstasy?, 3,4-methylenedioxymethamphetamine (MDMA), an amphetamine analogue is one of the most widely used recreational drugs. In spite of the fact that neurotoxic effects of MDMA has been found in several species from rodents to non-human primates, and results increasingly point to damage also in human MDMA users, data about the sensitivity of different brain areas and the recovery after neuronal damage are scarce. These studies were designed to characterize MDMA-induced damage and recovery of the serotonergic system including sleep and morphological changes within 180 days. Our findings concerning the changes detected in 5-HTT mRNA expression and fibre density indicate lasting impairment of the serotonergic system and suggest that a single use of MDMA may be associated with...